JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursors

Shinya Yari(The University of Osaka), Masaru Ishii(The University of Osaka), Kazuya Kikuchi(The University of Osaka), Masafumi Minoshima(The University of Osaka), Yu Miyamoto(Ube Frontier University), Hotaka Shigyo(The University of Osaka), Daisuke Okuzaki(The University of Osaka), Yuki Furusawa(ABB (Japan)), Junichi Kikuta(National Institute of Biomedical Innovation, Health and Nutrition)
Inflammation and Regeneration
March 3, 2023
10.1186/s41232-023-00268-4
Cited by 18

Related Papers

Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1
|Nature Immunology|2019|180
Periportal macrophages protect against commensal-driven liver inflammation
|Nature|2024|109
SLPI is a critical mediator that controls PTH-induced bone formation
|Nature Communications|2021|43
High-endothelial cell-derived S1P regulates dendritic cell localization and vascular integrity in the lymph node
|eLife|2019|38
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
|Nature Communications|2023|34